Cyclenium Pharma

Montreal, Canada Founded: 2013 • Age: 13 yrs Acquired By SpiroChem
Canadian, preclinical-stage biopharma developing macrocycle drugs for oncology, infections, and pain
Request Access

About Cyclenium Pharma

Cyclenium Pharma is a company based in Montreal (Canada) founded in 2013 by Mark Peterson was acquired by SpiroChem in June 2023.. Cyclenium Pharma offers products and services including CMRT Technology and Contract Research Services.

  • Headquarter Montreal, Canada
  • Founders Mark Peterson
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cyclenium Pharma
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    SpiroChem

    (Jun 12, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cyclenium Pharma

Cyclenium Pharma offers a comprehensive portfolio of products and services, including CMRT Technology and Contract Research Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Proprietary system for developing small-molecule macrocycles to target difficult diseases

Custom services for pharmaceutical firms to explore macrocycles in drug development

Funding Insights of Cyclenium Pharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Cyclenium Pharma

Cyclenium Pharma has secured backing from 1 investor. Prominent investors backing the company include SpiroChem. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Cyclenium Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Cyclenium Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cyclenium Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Cyclenium Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cyclenium Pharma

Frequently Asked Questions about Cyclenium Pharma

When was Cyclenium Pharma founded?

Cyclenium Pharma was founded in 2013.

Where is Cyclenium Pharma located?

Cyclenium Pharma is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.

What does Cyclenium Pharma do?

Cyclenium Pharma was established in 2013 in Montreal, Canada, as a spin-out from Tranzyme Pharma after its merger with Ocera Therapeutics. Focus is placed on preclinical development of macrocycle therapeutics targeting oncology, infections, and pain. Proprietary CMRT technology is utilized for drug discovery, alongside the QUEST Library of macrocyclic compounds. Partnerships have been formed with entities such as Astellas Pharma and Halpogen GmbH to advance operations in the biopharmaceutical sector.

What products or services does Cyclenium Pharma offer?

Cyclenium Pharma offers CMRT Technology and Contract Research Services.

Who are Cyclenium Pharma's investors?

Cyclenium Pharma has 1 investor. Key investors include SpiroChem.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available